PlainRecalls
FDA Drug Low Class III Terminated

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 --- NDC 0409-1140-01

Reported: July 26, 2017 Initiated: July 6, 2017 #D-0980-2017

Product Description

Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 --- NDC 0409-1140-01

Reason for Recall

Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point

Details

Units Affected
701 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 --- NDC 0409-1140-01. Recalled by Hospira Inc., A Pfizer Company. Units affected: 701 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point
Which agency issued this recall?
This recall was issued by the FDA Drug on July 26, 2017. Severity: Low. Recall number: D-0980-2017.